CNO Financial Group (NYSE: CNO) CMO Discloses Rule 10b5-1 Stock Sales

Rhea-AI Filing Summary

CNO Financial Group’s Chief Marketing Officer, who is an officer of the company, reported two sales of common stock. On December 15, 2025, the officer sold 6,051 shares at $42.25 and 3,232 shares at $43.25. After these transactions, the officer beneficially owned 73,932 shares of CNO common stock. The shares were sold pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TARASI ROCCO F III

(Last) (First) (Middle)

C/O CNO FINANCIAL GROUP, INC.

11299 ILLINOIS STREET, SUITE 200

(Street)

CARMEL IN 46032

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CNO Financial Group, Inc. [ CNO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Marketing Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/15/2025		S		6,051(1)	D	$42.25	77,164	D
Common Stock	12/15/2025		S		3,232(1)	D	$43.25	73,932	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares sold pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2025.

Remarks:

	Heidi M. Krings, Attorney-in-Fact	12/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider stock transactions did CNO (CNO) report for its Chief Marketing Officer?

The Chief Marketing Officer of CNO Financial Group reported two sales of common stock on December 15, 2025, totaling 9,283 shares.

How many CNO common shares did the Chief Marketing Officer sell on December 15, 2025?

The officer sold 6,051 shares of CNO common stock in one transaction and 3,232 shares in a second transaction on December 15, 2025.

At what prices were the CNO (CNO) insider sales completed?

The Chief Marketing Officer sold 6,051 shares at $42.25 per share and 3,232 shares at $43.25 per share.

How many CNO shares does the Chief Marketing Officer own after these transactions?

Following the reported sales, the officer beneficially owned 73,932 shares of CNO Financial Group common stock.

Were the CNO insider sales made under a Rule 10b5-1 trading plan?

Yes. The shares were sold pursuant to a Rule 10b5-1 trading plan that was adopted on June 9, 2025, as noted in the explanation of responses.

Is this CNO insider transaction report filed by more than one reporting person?

No. The report indicates it is a Form filed by one reporting person, relating to the company’s Chief Marketing Officer.